Adjuvant high-dose interferon therapy for high-risk melanoma.
Publication
, Journal Article
Ready, N; Weinstock, MA
Published in: Arch Dermatol
December 2003
Duke Scholars
Published In
Arch Dermatol
DOI
ISSN
0003-987X
Publication Date
December 2003
Volume
139
Issue
12
Start / End Page
1635 / 1637
Location
United States
Related Subject Headings
- Treatment Outcome
- Randomized Controlled Trials as Topic
- Melanoma
- Interferons
- Humans
- Dermatology & Venereal Diseases
- Chemotherapy, Adjuvant
- Antineoplastic Agents
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ready, N., & Weinstock, M. A. (2003). Adjuvant high-dose interferon therapy for high-risk melanoma. Arch Dermatol, 139(12), 1635–1637. https://doi.org/10.1001/archderm.139.12.1635
Ready, Neal, and Martin A. Weinstock. “Adjuvant high-dose interferon therapy for high-risk melanoma.” Arch Dermatol 139, no. 12 (December 2003): 1635–37. https://doi.org/10.1001/archderm.139.12.1635.
Ready N, Weinstock MA. Adjuvant high-dose interferon therapy for high-risk melanoma. Arch Dermatol. 2003 Dec;139(12):1635–7.
Ready, Neal, and Martin A. Weinstock. “Adjuvant high-dose interferon therapy for high-risk melanoma.” Arch Dermatol, vol. 139, no. 12, Dec. 2003, pp. 1635–37. Pubmed, doi:10.1001/archderm.139.12.1635.
Ready N, Weinstock MA. Adjuvant high-dose interferon therapy for high-risk melanoma. Arch Dermatol. 2003 Dec;139(12):1635–1637.
Published In
Arch Dermatol
DOI
ISSN
0003-987X
Publication Date
December 2003
Volume
139
Issue
12
Start / End Page
1635 / 1637
Location
United States
Related Subject Headings
- Treatment Outcome
- Randomized Controlled Trials as Topic
- Melanoma
- Interferons
- Humans
- Dermatology & Venereal Diseases
- Chemotherapy, Adjuvant
- Antineoplastic Agents
- 3202 Clinical sciences
- 1103 Clinical Sciences